Rosuvastatin ORBITAL Germany

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2002
The primary objective of the study is to compare the effect of rosuvastatin therapy plus compliance initiatives and rosuvastatin therapy alone for 12 months (52 weeks) on long-term cumulative direct and indirect disease-related costs during the 36 month.
Epistemonikos ID: 98a4a5f56d623aab04254506b96c0a2d27a2fbb3
First added on: May 04, 2024